4Tech ^Companies

4Tech has developed a proprietary transcatheter system — TriCinch™— for treatment of Tricuspid Regurgitation (TR). The system is designed to be an effective, simple and reproducible percutaneous procedure aiming to reduce TR. 4Tech has 5 employees at their 1 location and $36 m in total Company Profile - Office Locations, Competitors, Revenue …?